CCDC67 activators pertain to a specialized category of compounds that target and augment the activity of the coiled-coil domain-containing protein 67 (CCDC67). As a member of the coiled-coil protein family, CCDC67 is characterized by its structural motif, which consists of two or more alpha-helices wrapped around each other in a supercoil configuration. This structural feature is often implicated in facilitating protein-protein interactions, suggesting that CCDC67 may play a role in various cellular processes through its involvement in complex formation with other proteins. The precise biological functions of CCDC67 remain largely enigmatic, but it is thought to contribute to the intricate network of intracellular signaling and structural scaffolding. Activators of CCDC67 are therefore designed to enhance the protein's function, potentially by promoting its proper folding, stability, or its interaction with other cellular components. These activators could work by binding directly to CCDC67, altering its conformation in a way that favors interaction with other proteins, or by modulating the pathways that regulate its expression and activity.
The study and development of CCDC67 activators demand a nuanced approach that combines chemical biology with molecular techniques. Initial discovery is often driven by screening chemical libraries for molecules that exhibit the capacity to increase the activity of CCDC67, as measured by various in vitro assays. These assays might track changes in the protein's stability, its binding affinity for partner proteins, or its ability to perform its putative functions within the cell. Upon identification, CCDC67 activators are subjected to further investigation to delineate their mechanism of action. Critical to this process are techniques such as surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC), which can offer insights into the kinetics and thermodynamics of activator binding. Additionally, structural biology methods, including X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, might be utilized to visualize the exact manner in which activators interact with CCDC67 at the atomic level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could theoretically upregulate CCDC67 expression by reducing DNA methylation levels, thereby stimulating transcriptional activation of its gene promoter. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may elevate CCDC67 levels by inhibiting histone deacetylase, leading to acetylation of histones near the CCDC67 gene and promoting transcriptional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
By binding to retinoic acid receptors, retinoic acid might activate genetic pathways that stimulate CCDC67 transcription, raising its expression profile in certain cell types. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could enhance CCDC67 synthesis by increasing intracellular cAMP, which activates protein kinase A (PKA) and leads to the activation of transcription factors that drive CCDC67 gene transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate may stimulate the transcription of CCDC67 through epigenetic modifications, including increased histone acetylation and DNA demethylation processes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could lead to the upregulation of CCDC67 by activating sirtuins that promote deacetylation of specific transcription factors, enhancing their ability to stimulate CCDC67 gene expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane might induce the expression of CCDC67 by activating the Nrf2 pathway, which can lead to the transcriptional activation of antioxidant response element (ARE)-driven genes, possibly including CCDC67. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could potentially lead to increased transcription of the CCDC67 gene by stimulating transcription factors or kinases that target the CCDC67 promoter region. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could promote the transcription of CCDC67 by increasing histone acetylation levels, thereby creating a more accessible chromatin state for transcription machinery to upregulate CCDC67 expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may enhance CCDC67 gene transcription by activating glucocorticoid receptors, which can bind to glucocorticoid response elements in the CCDC67 gene promoter. | ||||||